Pollak M - Search Results

1

Treatment with insulin analog X10 and IGF-1 increases growth of colon cancer allografts.

Hvid H, Blouin MJ, Birman E, Damgaard J, Poulsen F, Fels JJ, Fledelius C, Hansen BF, Pollak M. Hvid H, et al. Among authors: pollak m. PLoS One. 2013 Nov 18;8(11):e79710. doi: 10.1371/journal.pone.0079710. eCollection 2013. PLoS One. 2013. PMID: 24260289 Free PMC article.

2

Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist.

Pollak M, Blouin MJ, Zhang JC, Kopchick JJ. Pollak M, et al. Br J Cancer. 2001 Aug 3;85(3):428-30. doi: 10.1054/bjoc.2001.1895. Br J Cancer. 2001. PMID: 11487276 Free PMC article.

3

Growth inhibition of breast epithelial cells by celecoxib is associated with upregulation of insulin-like growth factor binding protein-3 expression.

Levitt RJ, Buckley J, Blouin MJ, Schaub B, Triche TJ, Pollak M. Levitt RJ, et al. Among authors: pollak m. Biochem Biophys Res Commun. 2004 Apr 2;316(2):421-8. doi: 10.1016/j.bbrc.2004.02.062. Biochem Biophys Res Commun. 2004. PMID: 15020235

4

A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model.

Majeed N, Blouin MJ, Kaplan-Lefko PJ, Barry-Shaw J, Greenberg NM, Gaudreau P, Bismar TA, Pollak M. Majeed N, et al. Among authors: pollak m. Oncogene. 2005 Jul 7;24(29):4736-40. doi: 10.1038/sj.onc.1208572. Oncogene. 2005. PMID: 15870705

5

Insulin-like growth factor receptor I targeting in epithelial ovarian cancer.

Gotlieb WH, Bruchim I, Gu J, Shi Y, Camirand A, Blouin MJ, Zhao Y, Pollak MN. Gotlieb WH, et al. Gynecol Oncol. 2006 Feb;100(2):389-96. doi: 10.1016/j.ygyno.2005.09.048. Epub 2005 Nov 21. Gynecol Oncol. 2006. PMID: 16300820

6

The hedgehog pathway inhibitor cyclopamine increases levels of p27, and decreases both expression of IGF-II and activation of Akt in PC-3 prostate cancer cells.

Levitt RJ, Zhao Y, Blouin MJ, Pollak M. Levitt RJ, et al. Among authors: pollak m. Cancer Lett. 2007 Oct 8;255(2):300-6. doi: 10.1016/j.canlet.2007.05.006. Epub 2007 Jun 28. Cancer Lett. 2007. PMID: 17602833

7

Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.

Singh RP, Deep G, Blouin MJ, Pollak MN, Agarwal R. Singh RP, et al. Carcinogenesis. 2007 Dec;28(12):2567-74. doi: 10.1093/carcin/bgm218. Epub 2007 Oct 4. Carcinogenesis. 2007. PMID: 17916909

8

Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.

Raina K, Blouin MJ, Singh RP, Majeed N, Deep G, Varghese L, Glodé LM, Greenberg NM, Hwang D, Cohen P, Pollak MN, Agarwal R. Raina K, et al. Among authors: pollak mn. Cancer Res. 2007 Nov 15;67(22):11083-91. doi: 10.1158/0008-5472.CAN-07-2222. Cancer Res. 2007. PMID: 18006855

9

Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth.

Algire C, Zakikhani M, Blouin MJ, Shuai JH, Pollak M. Algire C, et al. Among authors: pollak m. Endocr Relat Cancer. 2008 Sep;15(3):833-9. doi: 10.1677/ERC-08-0038. Epub 2008 May 9. Endocr Relat Cancer. 2008. PMID: 18469156

10

Loss of function of PTEN alters the relationship between glucose concentration and cell proliferation, increases glycolysis, and sensitizes cells to 2-deoxyglucose.

Blouin MJ, Zhao Y, Zakikhani M, Algire C, Piura E, Pollak M. Blouin MJ, et al. Among authors: pollak m. Cancer Lett. 2010 Mar 28;289(2):246-53. doi: 10.1016/j.canlet.2009.08.021. Epub 2009 Sep 9. Cancer Lett. 2010. PMID: 19744772

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

865 results

Search Page

Filters